3188 results for «519»
3188 results
How CT fusion can empower your structural heart procedures
18 May 2021 – From EuroPCR 2021
Watch this session presented by Thomas Modine, Erwan Donal, Julia Grapsa and Ronak Rajani in order to learn how the novel tools in 4D TEE can help improving visualisation, navigation and communication within the heart team and how to better plan your structural heart procedures with Echo...
EuroPCR 2021 Hotlines / Late-Breaking Trials in physiology: FAST II, TARGET FFR, P3, OLV Pullback, France PCI, and more!
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in imaging:
- Angiography based Fractional Flow Reserve: the FAST II trial
- Instantaneous wave-free ratio for the assessment of nonculprit lesions
- Capacity of the PPG to predict functional revascularisation
- Clinical impact of FFR guided PCI
Coronary physiology in STEMI: is OpSens OptoWire III a game-changer in complete revascularisation?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Thomas Engstrom, Zsolt Piroth, Jacques Monsegu and Giuseppe Biondi-Zoccai in order to get an update on the latest evidence in physiology-guided full revascularisation in STEMI patients, to discover how the innovative physiology wire, OptoWire III from OpSens may lower the barriers to approach...
Contemporary adoption of invasive coronary physiology with microcatheter-based technology
19 May 2021 – From EuroPCR 2021
Watch this session presented by Emanuele Barbato, Bernard De Bruyne, Jeroen Sonck, Simone Biscaglia, Salvatore Brugaletta and Carlos Collet in order to understand the role of microcatheter-based physiology also through a critical appraisal of the available literature, to know how to correctly adopt the novel TruePhysio microcatheter, and...
PCI of calcified coronaries - we will rock you! (Part 2) - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to revisit strategies and devices for treatment of calcified plaque, to discuss the role of available options and to review in-depth procedural techniques for Orbital atherectomy.
This session was originally presented during EuroPCR 2021.
Leading with evidence, latest clinical outcomes update for Firesorb, Firehawk and VitaFlow
19 May 2021 – From EuroPCR 2021
Watch this session presented by Alexandra Lansky, Andreas Baumbauch, Junbo Ge and Bo Xu in order to learn about the one-year results from a pivotal RCT (FUTURE II), the four-year results from TARGET AC, and the four-year results from VitaFlow transcatheter aortic valve system in patients with severe aortic...
A case-based approach: finding balance between bleeding and ischemic risk
19 May 2021 – From EuroPCR 2021
Watch this session presented by David Kandzari, Mirvat Alasnag, Emmanouil Brilakis, Chorcheung Frankie Tam and Beatriz Vaquerizo in order to debate case complexity of patient characteristics and complex lesions in HBR patients, to review patient centered clinical judgment and individualised treatment plans, and to analyse current Onyx ONE...
PCI of calcified coronaries - we will rock you! - Part 3
18 May 2021 – From EuroPCR 2021
Watch this session if you want to revisit strategies and devices for treatment of calcified plaque, to discuss the role of available options and to review in-depth procedural techniques for IntraVascular Lithotripsy.
This session was originally presented during EuroPCR 2021.
Revascularisation for chronic coronary syndrome and multivessel disease (Part 1) - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation, to appraise how to select the optimal revascularisation strategy in such patients and to learn how to perform state-of-the-art PCI to achieve optimal procedural outcomes.
This session was originally presented...
Revascularisation for chronic coronary syndrome and multivessel disease - Part 2
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation and to appraise how to select the optimal revascularisation strategy in such patients.
This session was originally presented during EuroPCR 2021.
EuroPCR 2021 - Innovations in peripheral and structural interventions
18 May 2021 – From EuroPCR 2021
In this session, discover how an effective calcium debridement procedure in stenotic aortic valves may restore the valve function, and why biometric indicators and engineering characteristics are so important for effective and safe delivery of endovascular care.
Multivessel disease revascularisation: balancing the risk
19 May 2021 – From EuroPCR 2021
Watch this session presented by Jean Fajadet, Thomas Cuisset, Bruno Farah, Marek Grygier, Maciej Lesiak and Sylwia Iwanczyk in order to understand the selection of PCI for multivessel disease patients, to demonstrate the best treatment strategy for patients presenting with multivessel disease, and to discuss DAPT strategy in multivessel...
Challenges and opportunities in high-risk patients undergoing TAVI
19 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Raul Moreno and Peter Nordbeck in order to discuss the designing TAVI trial for high-risk patients, the timing of TAVI and PCI, as well as the balance between thrombosis prevention and bleeding mitigation
EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in bifurcation lesions:
- EBC MAIN - the European Bifurcation Club Left Main Coronary Bifurcation Study
- Clinical Outcomes after Physiology-Guided Treatment of Coronary Bifurcations
MagicTouch sirolimus coated balloon continues to be the choice of treatment for CAD
19 May 2021 – From EuroPCR 2021
Watch this session presented by Antonio Colombo, Aloke Finn, Sandeep Basavarajaiah, Gianluca Caiazzo and Bernardo Cortese in order to know where to use a DCB in today's clinical practice, to learn about real-world case-based experience and interesting data presentation from various registries and clinical studies, and to understand the technology...
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in drugs & devices:
- POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
- CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
- PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
The new Evolut PRO+ system: optimal procedural outcomes in all patients
20 May 2021 – From EuroPCR 2021
Watch this session presented by Didier Tchetche, Jean Fajadet, Azeem Latib, Anna Sonia Petronio, Daniel Blackman and Tanja Rudolph in order to explore benefits of the new Evolut PRO+ system and its versatility to treat different patient anatomies, to understand how the cusp overlap and commissural alignment techniques can...
Improving personalised vascular care using novel technologies: how can I start?
19 May 2021 – From EuroPCR 2021
Watch this session presented by Salvatore Brugaletta, Nick West, Rasha Al-Lamee, Will Davies, Angela H.E.M. Maas and William Wijns in order to learn more about personalised vascular healthcare, to understand the value of personalised vascular healthcare, and to see practical examples on how this can be implemented in your practice.
Why physiology and co-reg is helpful in treating patients with multivessel disease/diffused disease
20 May 2021 – From EuroPCR 2021
Watch this session presented by Sukhjinder Nijjer, Nick Curzen, Rasha Al-Lamee and Sayan Sen in order to learn about the new pressure guide wire OmniWire and workflow enhancement with Azurion and IntraSight, to understand how "interventional physiology" can guide PCI in diffuse, multivessel coronary artery disease, and to learn how...
Latest insights: when to choose orbital atherectomy
20 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Van Mieghem, Surendra Avula and Ajay Kirtane in order to understand the challenges of treating severe calcium, to know about the OAS overview with dual-action MOA technology and the clinical evidence supporting its use, and to be introduced to treatment technique.
